vimarsana.com

Page 6 - கேய்சிங்கேர் காமன்வெல்த் பள்ளி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

People you know

What it s like: Reporter gets his first COVID-19 vaccination

JENKINS TWP. — I got my shot. I won’t turn 65 for another 11 years, but I drove to the community vaccination clinic at the Geisinger CenterPoint Professional Office Building on Friday morning and got my first dose of Pfizer’s COVID-19 vaccine. I qualify during Phase 1A of Pennsylvania’s rollout because I have chronic obstructive pulmonary disorder. COPD is an inflammatory lung disease that causes obstructed airflow from the lungs. My supervisors knew of my condition, so when Geisinger invited the newspaper to have a reporter write about their own vaccination experience, they asked me if I was interested. I was.

Researchers find AI can predict new atrial fibrillation, stroke risk

 E-Mail DANVILLE, Pa. - A team of scientists from Geisinger and Tempus have found that artificial intelligence can predict risk of new atrial fibrillation (AF) and AF-related stroke. Atrial fibrillation is the most common cardiac arrhythmia and is associated with numerous health risks, including stroke and death. The study, published in Circulation, used electrical signals from the heart measured from a 12-lead electrocardiogram (ECG) to identify patients who are likely to develop AF, including those at risk for AF-related stroke. Each year, over 300 million ECGs are performed in the U.S. to identify cardiac abnormalities within an episode of care. However, these tests cannot generally detect future potential for negative events like atrial fibrillation or stroke, said Joel Dudley, chief scientific officer at Tempus. This critical work stems from our major investments in cardiology to generate algorithms that make existing cardiology tests, such as ECGs, smarter and capab

COVID-19 course tracks system pandemic response in real time | News, Sports, Jobs

Feb 26, 2021 SCRANTON When COVID-19 swept the globe, it caught the collective health care world off guard. While the national news was largely fixated on the bath tissue shortage, health systems were scrambling to shore up their supply of personal protective equipment and other infection-control necessities. Educators at Geisinger realized that Geisinger itself could provide the perfect case study in pandemic response to ensure better preparation for any future plague. As the coronavirus raged, educators and scientists at Geisinger developed a course, COVID-19: Health Systems and Pandemics, for audiences ranging from graduate and medical students, to healthcare practitioners looking for relevant continuing education credits and even to the general public interested in infectious disease, how it spreads and what an effective response entails.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.